Company Filing History:
Years Active: 2008
Title: The Innovations of Gary McGeorge
Introduction
Gary McGeorge is an accomplished inventor based in Franklin Park, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of factor Xa inhibitors. His work has the potential to impact the treatment of thromboembolic disorders.
Latest Patents
Gary McGeorge holds a patent for "Crystalline forms of a factor Xa inhibitor." This invention provides crystalline forms of 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide and its solvates. The patent also details processes for producing these crystalline forms, pharmaceutical compositions that include them, and methods for treating thromboembolic disorders using these compositions.
Career Highlights
Gary McGeorge is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work there focuses on innovative solutions in drug development, particularly in the area of anticoagulants.
Collaborations
Throughout his career, Gary has collaborated with notable colleagues, including Margaret M. Gleeson and Bang-Chi Chen. These partnerships have contributed to the advancement of research and development in the pharmaceutical industry.
Conclusion
Gary McGeorge's contributions to the field of pharmaceuticals, particularly through his patent on factor Xa inhibitors, highlight his innovative spirit and dedication to improving medical treatments. His work continues to pave the way for advancements in the management of thromboembolic disorders.